February 25, 2019
Keio University researchers have launched a clinical study on the Parkinson’s medicine ropinirole for the treatment of amyotrophic lateral sclerosis (ALS) after their iPS cell-based compound library screening identified its potential for use in the progressive neurodegenerative disease. Speaking at...read more